Position in RDY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$123,075,915
+$12,278,741 QoQ
Shares Held
8,493,852
+6.2% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
36.13%
of 13F equity value
Holder Rank
#5
of 238 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aikya Investment Management Ltd holds $123,075,915 across 1 Drug Manufacturers - Specialty & Generic name. RDY ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
This page
|
8,493,852 | $123,075,915 |
All Filings in RDY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,075,915 | 8,493,852 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $110,797,174 | 7,999,796 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $103,032,891 | 7,338,525 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $93,875,797 | 6,715,007 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $95,515,334 | 6,354,979 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $81,782,946 | 6,200,375 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $88,589,842 | 5,610,503 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $86,378,040 | 1,087,200 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $105,827,376 | 1,388,993 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $90,949,232 | 1,239,935 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $76,299,549 | 1,096,573 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||